Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Simona Di Giambenedetto, Massimiliano Fabbiani, Annalisa Mondi, Barbara Rossetti, Andrea De Luca, M. Zaccarelli, A. Latini, G. Sterrantino, G. D'Ettorre, P. Grima, B. Rossetti, B. Borchi, M. Giuliani, A. Antinori

Risultato della ricerca: Contributo in rivistaArticolo in rivista

4 Citazioni (Scopus)

Abstract

Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaHIV Medicine
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • STR
  • adherence
  • cART
  • combination antiretroviral therapy
  • toxicity

Fingerprint Entra nei temi di ricerca di 'Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen'. Insieme formano una fingerprint unica.

Cita questo